British healthcare technology firm, Tachmed, has confirmed the appointment of three senior team members as the company positions itself for its first product launch in 2024.

Among the new appointments, Marcus Teague takes the role of Quality Manager. Teague is a former British Army Telecommunications Specialist and boasts a wealth of experience in engineering. Speaking on his appointment, Teague says: "Since joining I have witnessed how Tachmed is transforming healthcare and the possibilities within the digital diagnostics sector. I'm very excited by the challenges that come with launching a groundbreaking product and want to ensure Tachmed is an intrinsic element in delivering the highest quality healthcare to everyone."

Lisa Mehany, previously from Zonal and BigTinCan, assumes the position of Digital Product Manager. She brings prior experience from the hospitality tech and intelligent sales solutions sectors. Upon her appointment, Mehany remarks: "I am looking forward to seeing the impact our Tachmed device can have on communities and our existing health services. We have big ambitions to shake up the healthcare industry and change the way people think about their own health, and I am proud to be a driving force behind that."

Also stepping into the fold is Matt Pounder who moves to Tachmed from Alten Group, a world leader in engineering and technology consulting. He will serve as Product Manager, bringing nearly two decades of experience from the aerospace sector. "This is a wonderful opportunity to be part of something that will impact and change so many lives for the better," says Pounder on his new role.

On the technological front, Tachmed’s first product is a smart health tech device and software system. The system, which utilises graphene-based technology, captures biomarkers of diseases through saliva samples, offering immediate results via a mobile app. This data can considerably assist clinicians in treating illnesses and give governments vital health insights to prevent future disease outbreaks.

Paul Christie, CEO and co-founder of Tachmed, expressed enthusiasm for the new recruitments stating: "As we move closer to launch, Marcus, Lisa and Matt will play a crucial part in our go-to-market strategy and I look forward to seeing the impact they will have given the array of experience they bring to our already strong team." He underscored that the Tachmed device typifies change in its vision, mission, and purpose, and envisions it as a tool to revolutionise personal health management and engagement with frontline health services.